SCHEMBL6515535

SCHEMBL6515535

NC(=O)Cc1cccc(OCCCN(CC(c2ccccc2)C2CCCCC2)C2CCN(C(=O)c3ccccc3)CC2)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR1H3 Q13133 11/20 0.46
CCR5 P51681 1/20 0.37
ALDH1A1 P00352 3/20 0.37
NR1H2 P55055 2/20 0.37
MEN1 O00255 1/20 0.37
NR1I2 O75469 1/20 0.37
MAPT P10636 1/20 0.37
RXRA P19793 1/20 0.37
VHL P40337 1/20 0.37
RECQL P46063 1/20 0.37
BLM P54132 1/20 0.37
KMT2A Q03164 1/20 0.37
MGLL Q99685 1/20 0.37
KDM4E B2RXH2 1/20 0.36
LMNA P02545 1/20 0.36
GAA P10253 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
SPHK2 Q9NRA0 1/20 0.36
SPHK1 Q9NYA1 1/20 0.36
FAAH O00519 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6510586 0.92 NR1H3 (0.48) NR1H3CCR5ALDH1A1NR1H2MEN1
SCHEMBL6515170 0.91 NR1H3 (0.44) NR1H3MEN1KMT2AF10
SCHEMBL6515146 0.90 NR1H3 (0.55) NR1H3CCR5ALDH1A1NR1H2MEN1
SCHEMBL6513610 0.90 NR1H3 (0.45) NR1H3CCR5ALDH1A1NR1H2MEN1
SCHEMBL6689959 0.86 MEN1 (0.37) ALDH1A1MEN1KMT2AKDM4ELMNA
SCHEMBL6515545 0.85 NR1H3 (0.44) NR1H3CCR5NR1H2MEN1RXRA
SCHEMBL6513607 0.84 NR1H3 (0.46) NR1H3CCR5ALDH1A1NR1H2MEN1
SCHEMBL6512055 0.84 NR1H3 (0.45) NR1H3ALDH1A1MEN1MAPTKMT2A
SCHEMBL6519566 0.84 NR1H3 (0.42) NR1H3CCR5ALDH1A1SMN1; SMN2SPHK2
SCHEMBL6515253 0.83 OPRK1 (0.51) NR1H3CCR5KMT2AFAAH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1318976-B1 SUBSTITUTED AMINOPROPOXYARYL DERIVATIVES USEFUL AS AGONISTS FOR LXR GLAXO GROUP LTD (GB) 2004-11-24 EP claimed
US-20040072868-A1 Substitued aminopropoxyaryl derivatives useful as agonists for lxr SMITHKLINE BEECHAM CORPORATION 2004-04-15 US claimed
US-20050282908-A1 Substituted aminopropoxyaryl derivatives useful as agonists for LXR SMITHKLINE BEECHAM CORPORATION 2005-12-22 US disclosed
EP-1318976-B1 SUBSTITUTED AMINOPROPOXYARYL DERIVATIVES USEFUL AS AGONISTS FOR LXR GLAXO GROUP LTD (GB) 2004-11-24 EP disclosed
US-20040072868-A1 Substitued aminopropoxyaryl derivatives useful as agonists for lxr SMITHKLINE BEECHAM CORPORATION 2004-04-15 US disclosed
EP-1318976-A2 SUBSTITUTED AMINOPROPOXYARYL DERIVATIVES USEFUL AS AGONISTS FOR LXR GLAXO GROUP LIMITED (GB) 2003-06-18 EP disclosed
WO-2002024632-A2 SUBSTITUTED AMINOPROPOXYARYL DERIVATIVES USEFUL AS AGONISTS FOR LXR GLAXO GROUP LIMITED (GB) 2002-03-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050282908-A1 Substituted aminopropoxyaryl derivatives useful as agonists for LXR NR1H3, NR1H2, NR1H4 NR1H3 1/4885CCR5 607/4885ALDH1A1 934/4885
US-20040072868-A1 Substitued aminopropoxyaryl derivatives useful as agonists for lxr NR1H2, NR1H3, NR1H4 NR1H3 2/4885CCR5 922/4885ALDH1A1 565/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.